Detailed Information
Cited 7 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A phase I dose-escalation and expansion study of JPI-547, a dual inhibitor of PARP/tankyrase in patients with advanced solid tumors.
- Authors
- Im, SA[Im, Seock-Ah]; Lee, S[Lee, SeungHwan]; Lee, KW[Lee, Keun Wook]; Lee, Y[Lee, Youngjoo]; Sohn, J[Sohn, Joohyuk]; Kim, JH[Kim, Jee Hyun]; Im, YH[Im, Young-Hyuck]; Park, KH[Park, Kyong Hwa]; Oh, DY[Oh, Do-Youn]; Kim, MH[Kim, Min Hwan]; Park, YH[Park, Yeon Hee]; Kim, TM[Kim, Tae Min]; Choi, YJ[Choi, Yoon Ji]; Lee, CS[Lee, Chang-Seok]; Park, J[Park, Jiseon]; Baek, NS[Baek, Nam Seok]; Choi, M[Choi, MiKyung]; Kim, J[Kim, John]; Yu, E[Yu, Eunyoung]; Bang, YJ[Bang, Yung-Jue]
- Issue Date
- 20-May-2021
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.39, no.15
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 39
- Number
- 15
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.